跳至主要内容
临床试验/EUCTR2010-021798-34-GB
EUCTR2010-021798-34-GB进行中(未招募)不适用

To assess the subjective effect of two paracetamol preparations on the feeling of breathing in subjects with the common cold.

GlaxoSmithKline Consumer Healthcare (GSKCH)0 个研究点开始时间: 2010年8月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Aged at least 18 years.
  • 2. Consent
  • Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • 3. Diagnosis at screening
  • a.Present no more than 120 hours ( 5 days) since first symptoms of common cold occur.
  • b.Have a self-rating of at least ‘moderate’ for nasal congestion at screening visit and a minimum of '2' on at least two of the VRS scales' (one of which must be blocked nose).
  • c.Have at least 4 symptoms associated with the common cold and flu
  • 4. Compliance
  • Understands and is willing, able and likely to comply with all study procedures and restrictions.
  • 5. General Health
  • Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or physical examination.
  • 6. Contraception
  • Females of childbearing potential who are in the opinion of the investigator, practising a reliable method of contraception.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnancy
  • Women who are known to be pregnant, or who have a positive pregnancy test.
  • 2. Breast-feeding
  • Women who are breast- feeding.
  • 3. Disease
  • a)Have a history of perennial allergic rhinitis or other chronic respiratory disease that (in the opinion of the investigator) is clinically significant.
  • b)Have a history of psychiatric illness (including psychiatric and neurological conditions) that may affect assessments.
  • 4. Medications
  • a.Have used any medication to treat their cold (antibiotics in the last 7 days, antihistamine in the last 72 hours, analgesics or antipyretics in the last 24 hours, decongestant in the last 12 hours, antitussive, medicated lozenge or throat spray in the last 8 hours) prior to screening.
  • b.Have taken any menthol containing product in the 2 hours before screening
  • Have consumed alcohol in the last 6 hours prior to screening.
  • 6. Allergy/Intolerance
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
  • 7. Clinical Study/Experimental Medication
  • a)Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
  • b)Previous treatment in this study.
  • 8. Personnel
  • An employee of the sponsor or the study site or members of their immediate family.

研究者

发起方
GlaxoSmithKline Consumer Healthcare (GSKCH)

相似试验